The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABBVIE INC | COM | 00287Y109 | 68,954 | 1,177,900 | SH | SOLE | 1,177,900 | 0 | 0 | ||
| ADMA BIOLOGICS INC | COM | 000899104 | 9,668 | 986,507 | SH | SOLE | 986,507 | 0 | 0 | ||
| AKORN INC | COM | 009728106 | 92,097 | 1,938,485 | SH | SOLE | 1,938,485 | 0 | 0 | ||
| ANACOR PHARMACEUTICALS INC | COM | 032420101 | 48,024 | 830,151 | SH | SOLE | 830,151 | 0 | 0 | ||
| ANI PHARMACEUTICALS INC | COM | 00182C103 | 70,348 | 1,124,667 | SH | SOLE | 1,124,667 | 0 | 0 | ||
| BIOTIME INC | COM | 09066L105 | 7,965 | 1,602,550 | SH | SOLE | 1,602,550 | 0 | 0 | ||
| CARDIOVASCULAR SYS INC DEL | COM | 141619106 | 85,595 | 2,192,500 | SH | SOLE | 2,192,500 | 0 | 0 | ||
| CATALYST PHARM PARTNERS INC | COM | 14888U101 | 21,000 | 4,849,870 | SH | SOLE | 4,849,870 | 0 | 0 | ||
| DERMA SCIENCES INC | COM PAR $.01 | 249827502 | 13,828 | 1,632,627 | SH | SOLE | 1,632,627 | 0 | 0 | ||
| EAGLE PHARMACEUTICALS INC | COM | 269796108 | 30,828 | 735,922 | SH | SOLE | 735,922 | 0 | 0 | ||
| EHEALTH INC | COM | 28238P109 | 496 | 52,900 | SH | SOLE | 52,900 | 0 | 0 | ||
| ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 47,552 | 1,552,962 | SH | SOLE | 1,552,962 | 0 | 0 | ||
| EPIRUS BIOPHARMACEUTICALS IN | COM | 29428P107 | 13,638 | 1,523,773 | SH | SOLE | 1,523,773 | 0 | 0 | ||
| HEALTHWAYS INC | COM | 422245100 | 33,811 | 1,716,307 | SH | SOLE | 1,716,307 | 0 | 0 | ||
| HYPERION THERAPEUTICS INC | COM | 44915N101 | 87,299 | 1,901,930 | SH | SOLE | 1,901,930 | 0 | 0 | ||
| INSYS THERAPEUTICS INC NEW | COM NEW | 45824V209 | 79,013 | 1,359,247 | SH | SOLE | 1,359,247 | 0 | 0 | ||
| MERUS LABS INTL INC NEW | COM | 59047R101 | 2,874 | 1,368,614 | SH | SOLE | 1,368,614 | 0 | 0 | ||
| ORTHOFIX INTL N V | COM | N6748L102 | 56,714 | 1,580,218 | SH | SOLE | 1,580,218 | 0 | 0 | ||
| OSIRIS THERAPEUTICS INC NEW | COM | 68827R108 | 21,067 | 1,198,336 | SH | SOLE | 1,198,336 | 0 | 0 | ||
| PACIFIC BIOSCIENCES CALIF IN | COM | 69404D108 | 11,697 | 2,002,971 | SH | SOLE | 2,002,971 | 0 | 0 | ||
| PERNIX THERAPEUTICS HLDGS IN | COM | 71426V108 | 34,865 | 3,261,484 | SH | SOLE | 3,261,484 | 0 | 0 | ||
| PROTALIX BIOTHERAPEUTICS INC | COM | 74365A101 | 10,046 | 5,643,750 | SH | SOLE | 5,643,750 | 0 | 0 | ||
| RETROPHIN INC | COM | 761299106 | 74,461 | 3,107,710 | SH | SOLE | 3,107,710 | 0 | 0 | ||
| SUPERNUS PHARMACEUTICALS INC | COM | 868459108 | 43,124 | 3,566,923 | SH | SOLE | 3,566,923 | 0 | 0 | ||
| UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 122,806 | 712,186 | SH | SOLE | 712,186 | 0 | 0 | ||
| VERACYTE INC | COM | 92337F107 | 1,717 | 235,860 | SH | SOLE | 235,860 | 0 | 0 | ||
| VERICEL CORP | COM | 92346J108 | 8,706 | 2,352,940 | SH | SOLE | 2,352,940 | 0 | 0 | ||